Completed
Ongoing
Investigater-Initiated Trial
New Drugs
- Project
- Indication
- Pre-clinical
- Phase I
- Phase II
- Phase III
- NDA
- D07001(Oral Gemcitabine)
- Biliary Tract Cancer
- Pancreatic Cancer
- IIT
- Lung Cancer
- IIT
- Project
- Indication
- Pre-clinical
- Phase I
- Phase (II)III
- NDA/BLA
- D0191801(Oral Insulin)
- Diabetes
- D0221901(Oral Semaglutide)
- Type II Diabetes
- Project
- Indication
- Pre-clinical
- Pre-BE studay
- BE studay
- NDA
- D0292301
- Pulmonary
hypertension
(PAH & CTEPH)
- Project
- Indication
- Pre-clinical
- Pre-BE studay
- BE studay
- ANDA
- D0282102
- Lymphocytic leukemia/
Multiple myeloma/
non-Hodgkin's lymphoma
- Project
- Indication
- R&D
- ANDA
- O0242001-1(Gadopentetate Dimeglumine)
- MRI Agent
- O0242001-2(Gadopentetate Meglumine)
- MRI Agent
- O0242001-3(Gadobutrol)
- MRI Agent
